Percutaneous Coronary Intervention (PCI)

No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment

No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment

By

There is no difference between heparin and bivalirudin in terms of platelet aggregation or coagulation markers after pretreatment with ticagrelor in patients undergoing PPCI.

Same Day Discharge Post-Elective PCI Safe and Generates Cost Savings

Same Day Discharge Post-Elective PCI Safe and Generates Cost Savings

By

Same day hospital discharge has the potential increase the overall value of PCI care and save US hospitals approximately $577 million if implemented more consistently.

ACE Inhibitors Reduce MACE Incidence in NSTEMI Post-Successful PCI

ACE Inhibitors Reduce MACE Incidence in NSTEMI Post-Successful PCI

By

Angiotensin-converting enzyme inhibitors reduced the incidence of revascularization and major adverse cardiac events, but had no beneficial effect on total deaths or recurrence of myocardial infarction.

PCI, CABG Both Acceptable for LMCAD With Chronic Kidney Disease

PCI, CABG Both Acceptable for LMCAD With Chronic Kidney Disease

For patients with LMCAD, those with and without CKD, undergoing revascularization have similar long-term outcomes with PCI and CABG.

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

By

Ticagrelor without aspirin offered no additional benefits compared with conventional dual antiplatelet therapy in patients undergoing PCI for either CAD or ACS.

SYNTAX Score II Predicts Mortality in 1- and 2-Vessel Disease

SYNTAX Score II Predicts Mortality in 1- and 2-Vessel Disease

By

The SYNTAX score II was an independent predictor of mortality in patients with 1- and 2-vessel disease undergoing percutaneous coronary intervention.

Doctors May Avoid Performing PCI Due to Public Reporting

Doctors May Avoid Performing PCI Due to Public Reporting

A total of 65% of cardiologists avoided percutaneous coronary intervention on 2 or more occasions due to reporting program concerns.

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

By

Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.

Improved Outcomes With CABG vs PCI for Diabetes With LV Dysfunction

Improved Outcomes With CABG vs PCI for Diabetes With LV Dysfunction

By

Aim of study was to determine whether treatment with percutaneous coronary intervention or coronary artery bypass grafting leads to improved outcomes in patients with diabetes, coronary artery disease, and left ventricular dysfunction.

Smartphone Application Shows Promise for Assessing Ulnar Artery Patency

Smartphone Application Shows Promise for Assessing Ulnar Artery Patency

By

The smartphone heart rate monitoring application had higher diagnostic accuracy compared with standard physical examination for determining ulnar artery patency prior to radial access.

Acute MI Hospital Mortality During Transcatheter Cardiovascular Therapeutics Meeting Dates

Acute MI Hospital Mortality During Transcatheter Cardiovascular Therapeutics Meeting Dates

Acute myocardial infarction 30-day mortality was lower during Transcatheter Cardiovascular Therapeutics meeting dates.

PCI: Prevalence and Effect of Silent Diabetes

PCI: Prevalence and Effect of Silent Diabetes

By

Abnormal glucose metabolism may be present in patients with undetected diabetes after percutaneous coronary intervention.

CABG May Have Better Outcomes Than PCI in Diabetes With LV Dysfunction

CABG May Have Better Outcomes Than PCI in Diabetes With LV Dysfunction

In patients with diabetes, multivessel coronary artery disease, and left ventricular dysfunction, coronary artery bypass grafting was associated with a reduction in major adverse cardiac and cerebrovascular events and mortality.

Cardiac Catheterization Labs May Be More Efficient With Quality Improvement Initiative

Cardiac Catheterization Labs May Be More Efficient With Quality Improvement Initiative

A quality improvement intervention can reduce inefficiencies in the cardiac catheterization lab.

Patent Foramen Ovale Closure Does Not Reduce Migraine Headaches

Patent Foramen Ovale Closure Does Not Reduce Migraine Headaches

By

Percutaneous closure of patent foramen ovale is not associated with a reduction in migraine headaches in patients with and without aura.

Post-CABG, PCI Medical Therapy Adherence

Post-CABG, PCI Medical Therapy Adherence

Compliance with guideline-directed medical therapy is low, but remains higher in PCI than in CABG.

CABG Offers Better Long-Term Outcomes in Younger Adults With CAD

CABG Offers Better Long-Term Outcomes in Younger Adults With CAD

Percutaneous coronary intervention is associated with increased rates of adverse outcomes compared with CABG in patients with 3-vessel CAD.

Multivessel CAD With Diabetes: Choosing an Optimal Revascularization Strategy

Multivessel CAD With Diabetes: Choosing an Optimal Revascularization Strategy

By

Patients with multivessel coronary artery disease and diabetes may benefit more from coronary artery bypass grafting surgery vs percutaneous coronary intervention.

Rates of Transradial Access for STEMI PCI Examined

Rates of Transradial Access for STEMI PCI Examined

Use of transradial access for STEMI percutaneous coronary intervention increased from 2009 to 2015.

Exercise Time After Percutaneous Coronary Intervention for Angina

Exercise Time After Percutaneous Coronary Intervention for Angina

Percutaneous coronary intervention does not increase exercise time more than a placebo procedure in patients with angina and severe coronary stenosis.

Genotype-Guided Antiplatelet Therapy Post-PCI May Be Beneficial

Genotype-Guided Antiplatelet Therapy Post-PCI May Be Beneficial

Alternative antiplatelet therapy after percutaneous coronary intervention in patients with a CYP2C19 loss-of-function allele may have lower risk of MACE compared to clopidogrel.

PCI and CABG Provide Similar Intermediate-Term Outcomes in Left Main CAD

PCI and CABG Provide Similar Intermediate-Term Outcomes in Left Main CAD

By

A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.

Post-PCI MACE Risk in Women, Minorities, and White Men

Post-PCI MACE Risk in Women, Minorities, and White Men

Women and minorities undergoing PCI with everolimus-eluting stents have a risk of MACE similar to that of white men.

Vitamin D as a Means of Cardioprotection in Elective PCI

Vitamin D as a Means of Cardioprotection in Elective PCI

Vitamin D did not produce a substantial preventive effect on cardiac injury during percutaneous coronary intervention.

Bleeding Risk Reduced in Atrial Fibrillation After PCI With Dual Therapy

Bleeding Risk Reduced in Atrial Fibrillation After PCI With Dual Therapy

For patients with atrial fibrillation who undergo percutaneous coronary intervention, the risk of bleeding is lower with dual therapy vs triple therapy.

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

By

In patients undergoing percutaneous coronary intervention for either STEMI or NSTEMI, bivalirudin and heparin produce similar outcomes.

Which Revascularization Strategy Produces Better Outcomes in Type 1 Diabetes?

Which Revascularization Strategy Produces Better Outcomes in Type 1 Diabetes?

By

Coronary artery bypass grafting yielded better outcomes in patients with type 1 diabetes who had multivessel disease compared with percutaneous coronary intervention.

CCTA Shows Diagnostic Accuracy Post-Vascular Scaffold Implantation

CCTA Shows Diagnostic Accuracy Post-Vascular Scaffold Implantation

Coronary computed tomography angiography is an accurate method of assessing angiographic outcomes after bioresorbable vascular scaffold implantation.

Heart Stents Coated With Sildenafil May Reduce Clots, Aortic Stenosis

Heart Stents Coated With Sildenafil May Reduce Clots, Aortic Stenosis

Sildenafil-coated stents may help reduce clots.

Ischemic Outcomes in Acute Coronary Syndrome Not Affected by Gender

Ischemic Outcomes in Acute Coronary Syndrome Not Affected by Gender

Gender has no effect on the outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention receiving clopidogrel, prasugrel, or ticagrelor.

Sign Up for Free e-Newsletters